Latest Breaking News On - Endo pharmaceuticals - Page 7 : comparemela.com

Petros Pharmaceuticals, Inc : Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA OTC Switch

Study paves the way toward a first-ever innovation program to include AI-optimization for FDA-guided Rx-to-OTC switch NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI)

Jules abrahamAuxilium pharmaceuticalsSecurities exchangePetros pharmaceuticalsEndo pharmaceuticalsPetros pharmaceuticals incExchange commissionDrug administrationFormative human factorsWeb appHuman factors studyFady boctorPetro presidentChief commercialDrug facts labelLabel comprehension studies

Nearly a dozen drug firms impacted by Cencora breach

Novartis Pharmaceuticals, Bayer, GlaxoSmithKline, and eight other major pharmaceutical firms have disclosed the compromise of their patients' information following a cyberattack against large U.S. pharmaceutical services provider Cencora, formerly known as AmericsourceBergen, in February, reports BleepingComputer.

United statesSumitomo pharma americaCencora incAcadia pharmaceuticalsNovartis pharmaceuticalsRegeneron pharmaceuticals incyteFlash groupDendreon pharmaceuticalsOffice of the california attorney generalEndo pharmaceuticalsRegeneron pharmaceuticalsCalifornia attorney

Data breach at medical giant Cencora exposes info from multiple drug companies

Almost a dozen drug providers report losing sensitive data

United statesSumitomo pharma americaRegeneron pharmaceuticalsAcadia pharmaceuticalsEndo pharmaceuticalsBayer corporationNovartis pharmaceuticals corporationDendreon pharmaceuticalsExchange commissionGlaxosmithkline groupGenentech incyte corporationCalifornia attorney generalIncyte corporationTechradar pro

Petros Pharmaceuticals, Inc : Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA

Team composed of former FDA officials and key clinical and regulatory opinion leaders to help provide insight in preparation for collaboration with FDANEW YORK, NY / ACCESSWIRE / May 21, 2024 / Petros

Jules abrahamExchange commissionAdvisory committeeDrug administrationSecurities exchangeEndo pharmaceuticalsPetros pharmaceuticalsPetros pharmaceuticals incAuxilium pharmaceuticalsFady boctorChief commercialDrug facts labelLabel comprehension studiesSelf selection studiesActual use trialAdditional conditions

Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC

Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Auxilium pharmaceuticalsEndo pharmaceuticalsPetros pharmaceuticals incDrug administrationPetros pharmaceuticalsAdvisory committeeNews networkPharmaceuticals activates advisory committeeHelp guideFady boctorChief commercialDrug facts labelLabel comprehension studiesSelf selection studiesActual use trialAdditional conditions